NDC Package 71334-225-12 Pyrukynd

Mitapivat Kit - View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

71334-225-12

Package Description:

1 KIT in 1 CARTON * 7 TABLET, FILM COATED in 1 BLISTER PACK (71334-210-07) * 7 TABLET, FILM COATED in 1 BLISTER PACK (71334-205-07)

Product Code:

71334-225

Proprietary Name:

Pyrukynd

Non-Proprietary Name:

Mitapivat

Usage Information:

PYRUKYND is indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

11-Digit NDC Billing Format:

71334022512

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

RxCUI: 2594473 - mitapivat 20 MG Oral Tablet
RxCUI: 2594473 - mitapivat 20 MG (as mitapivat sulfate 23.4 MG) Oral Tablet
RxCUI: 2594479 - pyrukynd 20 MG Oral Tablet
RxCUI: 2594479 - mitapivat 20 MG Oral Tablet [Pyrukynd]
RxCUI: 2594479 - Pyrukynd 20 MG (as mitapivat sulfate 23.4 MG) Oral Tablet

Product Type:

Human Prescription Drug

Labeler Name:

Agios Pharmaceuticals, Inc.

Dosage Form:

Kit - A packaged collection of related material.

Sample Package:

FDA Application Number:

NDA216196

Marketing Category:

NDA - A product marketed under an approved New Drug Application.

Start Marketing Date:

02-18-2022

Listing Expiration Date:

12-31-2026

Exclude Flag:

Code Structure:

71334 - Agios Pharmaceuticals, Inc.
- 71334-225 - Pyrukynd
  - 71334-225-12 - 1 KIT in 1 CARTON * 7 TABLET, FILM COATED in 1 BLISTER PACK (71334-210-07) * 7 TABLET, FILM COATED in 1 BLISTER PACK (71334-205-07)

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 71334-225-12?

The NDC Packaged Code 71334-225-12 is assigned to a package of 1 kit in 1 carton * 7 tablet, film coated in 1 blister pack (71334-210-07) * 7 tablet, film coated in 1 blister pack (71334-205-07) of Pyrukynd, a human prescription drug labeled by Agios Pharmaceuticals, Inc.. The product's dosage form is kit and is administered via form.

Is NDC 71334-225 included in the NDC Directory?

Yes, Pyrukynd with product code 71334-225 is active and included in the NDC Directory. The product was first marketed by Agios Pharmaceuticals, Inc. on February 18, 2022 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 71334-225-12?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units.

What is the 11-digit format for NDC 71334-225-12?

The 11-digit format is 71334022512. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	71334-225-12	5-4-2	71334-0225-12

Table of Contents